| III-14 Irina Baltcheva Model-based dose selection for the Phase 2b study of ianalumab in primary Sjögren's Syndrome Thursday 09:55-11:30 |
| III-14 Irina Baltcheva Model-based dose selection for the Phase 2b study of ianalumab in primary Sjögren's Syndrome Thursday 09:55-11:30 |